Literature DB >> 16224037

Treatment of acute hypocalcemia in critically ill multiple-trauma patients.

Roland N Dickerson1, Laurie G Morgan, April D Cauthen, Kathryn H Alexander, Martin A Croce, Gayle Minard, Rex O Brown.   

Abstract

BACKGROUND: Recent data indicate that critically ill, adult multiple trauma patients receiving specialized nutrition support commonly experience hypocalcemia (ionized serum calcium [iCa] < or =1.12 mmol/L). However, validated methods for the treatment of acute hypocalcemia are lacking.
METHODS: The efficacy of a single dose of calcium gluconate using an empiric IV calcium gluconate graduated dosing regimen was evaluated in 37 patients. Patients with an iCa of 1-1.12 mmol/L (mild hypocalcemia) were provided 1-2 g of IV calcium gluconate. Patients with an iCa of <1 mmol/L (moderate to severe hypocalcemia) were given 2-4 g. The calcium gluconate was infused at a rate of 1 g/h in a small-volume admixture. Serum iCa determination was repeated on the following day.
RESULTS: One to 2 g of IV calcium gluconate was effective in normalizing iCa for 23 out of 29 patients (79%) with mild hypocalcemia and 2-4 g was effective for 3 of 8 patients (38%) with moderate to severe hypocalcemia. The individual response to calcium therapy (g/d) or when normalized to body weight (mg/kg/d) was highly variable.
CONCLUSIONS: One to 2 g of IV calcium gluconate were effective for most patients with mild hypocalcemia; however, treatment of moderate to severe hypocalcemia with 2-4 g of IV calcium gluconate was often unsuccessful. Further study with frequent serial ionized serum calcium and phosphorus determinations and electrocardiographic monitoring appears to be indicated for patients with moderate to severe hypocalcemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16224037     DOI: 10.1177/0148607105029006436

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  4 in total

Review 1.  Hypocalcemia: updates in diagnosis and management for primary care.

Authors:  Jeremy Fong; Aliya Khan
Journal:  Can Fam Physician       Date:  2012-02       Impact factor: 3.275

2.  Severe, Symptomatic Hypocalcemia due to Denosumab Administration: Treatment and Clinical Course.

Authors:  Jarred Strickling; Michael J Wilkowski
Journal:  Case Rep Nephrol Dial       Date:  2019-04-23

3.  The Incidence, Degree, and Timing of Hypocalcemia From Massive Transfusion: A Retrospective Review.

Authors:  Christopher P Potestio; Noud Van Helmond; Nadder Azzam; Ludmil V Mitrev; Akhil Patel; Talia Ben-Jacob
Journal:  Cureus       Date:  2022-02-10

4.  Augmented Renal Clearance Following Traumatic Injury in Critically Ill Patients Requiring Nutrition Therapy.

Authors:  Roland N Dickerson; Christin N Crawford; Melissa K Tsiu; Cara E Bujanowski; Edward T Van Matre; Joseph M Swanson; Dina M Filiberto; Gayle Minard
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.